Prostate Cancer Hormone Therapy Tied to Higher Heart Risk

Amainstay of treatment for men who undergo surgery or radiation therapy for prostate cancer is medication to suppress the male hormones that feed the cancer cells. The treatment, known as androgen-deprivation therapy (ADT), plays a vital role in helping the vast majority of patients achieve remission or cure. But the tradeoff is a sharply increased risk of heart disease.